⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL157482 | 0.93 | — | — | |
| SCHEMBL1603142 | 0.86 | — | — | |
| Carbon Dioxide SCHEMBL74555 | 0.68 | — | — | |
| Carbon Dioxide SCHEMBL9555304 | 0.62 | — | — | |
| Carbon Dioxide SCHEMBL4622066 | 0.62 | — | — | |
| Carbon Dioxide SCHEMBL3954736 | 0.62 | — | — | |
| Carbon Dioxide SCHEMBL3988546 | 0.62 | — | — | |
| SCHEMBL3081530 | 0.62 | — | — | |
| Carbon Dioxide SCHEMBL9462778 | 0.62 | — | — | |
| Carbon Dioxide SCHEMBL28143754 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10158109-B2 | Multi-phase electrolyte lithium batteries | SEEO, INC. (US) | 2018-12-18 | — | — | US | disclosed |
| US-9923245-B2 | Fluorinated alkali ion electrolytes with urethane groups | SEEO, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-9893337-B2 | Multi-phase electrolyte lithium batteries | SEEO, INC. (US) | 2018-02-13 | — | — | US | disclosed |
| US-20160344008-A1 | MULTI-PHASE ELECTROLYTE LITHIUM BATTERIES | SEEO, INC | 2016-11-24 | — | — | US | disclosed |
| US-20160294012-A1 | FLUORINATED ALKALI ION ELECTROLYTES WITH URETHANE GROUPS | SEEO, INC | 2016-10-06 | — | — | US | disclosed |
| US-20160028114-A1 | MULTI-PHASE ELECTROLYTE LITHIUM BATTERIES | SEEO, INC | 2016-01-28 | — | — | US | disclosed |
| EP-2468277-A1 | Triptolide derivatives for modulation of apoptosis and immunosuppression | Pharmagenesis, Inc. (US) | 2012-06-27 | — | — | EP | disclosed |
| US-20110076293-A1 | TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION | DAI DONGCHENG | 2011-03-31 | — | — | US | disclosed |
| US-7847109-B2 | Triptolide derivatives for modulation of apoptosis and immunosuppression | PHARMAGENESIS, INC. (US) | 2010-12-07 | — | — | US | disclosed |
| US-7662976-B2 | Triptolide derivatives for modulation of apoptosis and immunosuppression | PHARMAGENESIS, INC. (US) | 2010-02-16 | — | — | US | disclosed |
| US-20090171103-A1 | Triptolide Derivatives for Modulation of Apoptosis and Immunosuppression | DAI DONGCHENG | 2009-07-02 | — | — | US | disclosed |
| EP-1511478-A2 | TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION | PHARMAGENESIS, INC. (US) | 2005-03-09 | — | — | EP | disclosed |
| US-20040235943-A1 | Triptolide derivatives for modulation of apoptosis and immunosuppression | PHARMAGENESIS, INC. | 2004-11-25 | — | — | US | disclosed |
| WO-2003101951-A2 | TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION | PHARMAGENESIS, INC. (US) | 2003-12-11 | — | — | WO | disclosed |